June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
CC2D2A mutations lead to variable phenotypes in a family with retinal dystrophy
Author Affiliations & Notes
  • Cécile Méjécase
    Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France
  • Saddek Mohand-Said
    Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France
    CHNO des Quinze-Vingts, DHU Sight Restore, INSERM-DHOS CIC1423, Paris, France
  • Camille Andrieux
    CHNO des Quinze-Vingts, DHU Sight Restore, INSERM-DHOS CIC1423, Paris, France
  • Aurélie Hummel
    Department of Nephrology, Necker-Enfants Malades Hospital, Paris, France
  • Saïd El Shamieh
    Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France
  • Aline Antonio
    Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France
    CHNO des Quinze-Vingts, DHU Sight Restore, INSERM-DHOS CIC1423, Paris, France
  • Fiona Boyard
    Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France
  • Christel Condroyer
    Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France
  • Christelle Michiels
    Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France
  • Steven Blanchard
    IntegraGen SA, Genopole, CAMPUS, Evry, France
  • Mélanie Letexier
    IntegraGen SA, Genopole, CAMPUS, Evry, France
  • Jean-Paul Saraiva
    IntegraGen SA, Genopole, CAMPUS, Evry, France
  • Jose Alain Sahel
    Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France
    CHNO des Quinze-Vingts, DHU Sight Restore, INSERM-DHOS CIC1423, Paris, France
  • Christina Zeitz
    Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France
  • Isabelle S Audo
    Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France
    CHNO des Quinze-Vingts, DHU Sight Restore, INSERM-DHOS CIC1423, Paris, France
  • Footnotes
    Commercial Relationships   Cécile Méjécase, None; Saddek Mohand-Said, None; Camille Andrieux, None; Aurélie Hummel, None; Saïd El Shamieh, None; Aline Antonio, None; Fiona Boyard, None; Christel Condroyer, None; Christelle Michiels, None; Steven Blanchard, None; Mélanie Letexier, None; Jean-Paul Saraiva, None; Jose Sahel, None; Christina Zeitz, None; Isabelle Audo, None
  • Footnotes
    Support  Foundation Fighting Blindness center grant [C-CMM-0907-0428-INSERM04], Fondation Voir et Entendre, Prix Dalloz for “La recherche en ophtalmologie”, LABEX LIFESENSES [reference ANR-10-LABX-65] supported by French state funds managed by the Agence Nationale de la Recherche within the Investissements d'Avenir program [ANR-11-IDEX-0004-0], Prix de la Fondation de l’Œil and doctoral funding from the Ministère de l’Enseignement Supérieur et de la Recherche (MESR).
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 573. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Cécile Méjécase, Saddek Mohand-Said, Camille Andrieux, Aurélie Hummel, Saïd El Shamieh, Aline Antonio, Fiona Boyard, Christel Condroyer, Christelle Michiels, Steven Blanchard, Mélanie Letexier, Jean-Paul Saraiva, Jose Alain Sahel, Christina Zeitz, Isabelle S Audo; CC2D2A mutations lead to variable phenotypes in a family with retinal dystrophy. Invest. Ophthalmol. Vis. Sci. 2017;58(8):573.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Inherited retinal dystrophies (IRDs) are a heterogeneous group of disorders characterized by progressive degeneration of photoreceptors. Many gene defects have been identified but they only account for 60% of the cases. The purpose of this study was to identify the gene defect(s) underlying IRD in three affected brothers from a consanguineous family.

Methods : Patients were clinically examined by standard methods. Targeted next-generation sequencing (NGS) covering 120 genes known to be mutated in IRD and subsequent whole exome sequencing (WES) were performed. Putative disease-causing variants identified after stringent filtering were confirmed by Sanger sequencing. Additional 960 probands with IRDs were analyzed by targeted NGS.

Results : Ophthalmic examination of the eldest brothers was in keeping with rod-cone dystrophy whereas the younger brother had early-onset cone-rod dystrophy. Renal function and ultrasound was normal in the eldest brothers whereas the youngest had high blood pressure, hematuria and proteinuria but no sign of glomerulonephritis on renal biopsy. Brain magnetic resonance imaging was normal for the three siblings. In addition, none of the siblings had learning disabilities and all were otherwise fit and well. Initial targeted NGS and subsequent WES did not identify any homozygous disease-causing variant. However, two heterozygous variants were identified in CC2D2A (c.2774G>C p.(Arg925Pro) and c.4730_4731delinsTGTATA p.(Ala1577Valfs*5)), confirmed by direct sequencing. Of note, CC2D2A was covered by targeted NGS approach, but the two variants were missed due to the expectation of homozygous mutations related to the reported consanguinity. Additional 960 probands with IRD screened by targeted NGS did not have CC2D2A mutations.

Conclusions : Mutations in CC2D2A were previously reported in Meckel-Gruber and Joubert Syndromes. Here we report new phenotypes associated with CC2D2A mutations in the same sibship including non-syndromic rod-cone dystrophy and cone-rod dystrophy with atypical renal feature. The link between renal and retinal abnormalities is not established in the later case and warrant further investigations. Mutations in CC2D2A underlying non-syndromic IRD account for less than 0.1%. Further studies are needed to understand the phenotype-genotype correlations in Meckel-Gruber Syndrome, Joubert Syndrome and in non-syndromic retinal dystrophy.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×